Page 1 of 12Free preview · 1–5

About this document

A clinical pathway primarily for pediatric patients at risk of vitamin D deficiency. Covers risk-based screening, 25-hydroxyvitamin D testing, interpretation of laboratory results, supplementation by age and weight status, follow-up, prevention, and endocrinology referral. Includes frequently asked questions, education resources, a sample laboratory test review letter, references, and clinical improvement team details. Originated November 3, 2014; last reviewed or revised August 25, 2020.

Free preview text

The first 5 pages, shown as text so search engines and readers can find this document.

Page 1

CLINICAL PATHWAY Page 1 of 12 VITAMIN D DEFICIENCY ALGORITHM Assess patient’s risk for vitamin D deficiency Is the patient at an increased risk? Obtain 25-hydroxy vitamin D lab evaluation • Repeat yearly diet/high risk screening • Consider maintenance dosing Were the results low? • Start supplementation based on dosing recommendations. • Repeat 25-hydroxy vitamin D lab assessment in 6-12 weeks Were the results low? • Confirm adequate dose • Check for adherence • Consider increasing dose • Repeat 25-hydroxy vitamin D lab assessment in 6-12 weeks Were the results low? Improved but low Persistent low Consider endocrinologist evaluation Normal Normal Normal Yes Yes Yes Yes Repeat yearly diet/high risk screening No Inclusion Criteria • Patients with risk factors for low vitamin D levels Exclusion Criteria • Patients with conditions that may require large doses and frequent follow up • Patients with rickets or hypercalcemia • Confirm adequate dose • Check for adherence • Consider increasing dose • Repeat 25-hydroxy vitamin D lab assessment in 6-12 weeks Check for adherence Patient risk factors: • Dark, covered skin, limited sun exposure • Low dietary intake • Exclusively breast fed infants (see specifics) • Premature birth • Chronic use of medications (see list) • Malabsorption problems • Liver failure, Chronic renal disease • Obesity (BMI greater than 95th percentile) • Osteoporosis /Low bone density Dosing chart: Lab results severity: • Severe Deficiency = Less than 12 ng/mL • Deficiency =13 to 19 ng/mL • Insufficiency = 20 to 29 ng/mL

Page 2

CLINICAL PATHWAY Page 2 of 12 PATHWAY SUMMARY Assessment Consider vitamin D screening in children with the following risk factors: • Dark or covered skin • Limited sun exposure • Low dietary intake • Any breast-fed or formula-fed infant unable to consume at least 1L/day of fortified breastmilk or formula, who is not already supplemented with the recommended Vitamin D dose (400 IU/10 mcg) • Chronic use of medications that impact vitamin D metabolism or absorption, or greatly increase risk of osteoporosis: including anticonvulsants, glucocorticoids, antifungals and medications used for the treatment of HIV • Malabsorption problems • Liver failure • Obesity (BMI >95th percentile) • Premature birth • Chronic renal disease or history of renal transplant • Osteoporosis • Low bone density Laboratory Study • Request for 1,25-dihydroxyvitamin D will be intercepted by the team and the provider form letter will be sent to the ordering provider Therapeutics • The Children’s Hospital Colorado Vitamin D Committee recommends that all individuals, who are supplemented, take once-daily vitamin D3 or its weekly equivalent to maintain serum 25(OH)D levels of at least 30 ng/mL. Recommendations for follow up: • Vitamin D levels should be rechecked after 6 to12 weeks of treatment. • Vitamin D can be evaluated sooner if medically indicated. • Consider annual surveillance in individuals that remain at-risk for vitamin D deficiency or when optimization of vitamin D status is a treatment goal for bone health. • Consider Endocrinology referral if deficiency is resistant to treatment, or in patients with osteoporosis and low bone density. Prevention Information regarding appropriate sun exposure, the use of vitamin D supplements, and eating a diet rich in calcium and vitamin D should be made available to each patient.

Page 3

CLINICAL PATHWAY Page 3 of 12 TABLE OF CONTENTS Algorithm Target Population Background | Definitions Initial Evaluation – see Recommendation for Screening Laboratory Studies | Imaging Therapeutics Prevention Frequently Asked Questions Parent | Caregiver Education Appendix A. Sample Laboratory Request Letter References Clinical Improvement Team TARGET POPULATION Inclusion Criteria • Patients with risk factors for low vitamin D levels Exclusion Criteria • Pediatric patients with chronic medical conditions which may require large doses and more frequent follow up. • Patients with severe deficiency leading to rickets or other conditions associated with hypercalcemia. BACKGROUND | DEFINITIONS Vitamin D is a fat-soluble vitamin that the body makes from cholesterol through the action of the sun’s UVB rays on the skin. Factors such as skin color, age, amount and time of sun exposure, and geographic location affect how much vitamin D the body makes. The primary function of vitamin D is to maintain normal blood concentrations of calcium and phosphorus, to support bone health as normal bone mineralization depends on adequate calcium and phosphate1 Low vitamin D levels may result in decreased calcium and phosphate concentrations, and secondary hyperparathyroidism causing inadequate mineralization and loss of skeletal mass. When growth plates are closed, this can lead to osteomalacia; if the growth plates have not closed, rickets may develop. It has also been suggested that vitamin D may have additional benefits on cardiovascular, pancreatic, muscle and brain health. RECOMMENDATION FOR SCREENING Note: Screening for vitamin D levels should be reserved for patients with risk factors for deficiency or when optimization of vitamin D is a treatment goal for bone health. Universal screening of all patients is not recommended2,3. Consider assessing vitamin D status in children with the following risk factors: • Dark skin1 • Limited sun exposure, including frequent sunscreen use and cultural convention associated with covering body3 • Low dietary intake, including vegan/macrobiotic diets, milk avoiders or patients with allergy/intolerance3

Page 4

CLINICAL PATHWAY Page 4 of 12 • Chronic use of medications that impair vitamin D metabolism or absorption (e.g. anticonvulsants, steroids [including inhaled], antifungals and medications used for the treatment of HIV)2 • Malabsorption problems (including celiac disease, cystic fibrosis, etc.)2 • Obesity1 (95th percentile) • Premature birth3 • Infants of breastfeeding mothers with dark skin or covered (minimal skin exposure) without vitamin D supplementation or low intake of foods containing vitamin D. Any breast-fed or formula-fed infant unable to consume at least 1L/day of fortified breastmilk or formula is at increased risk of vit D deficiency 3. • Malabsorption problems • Chronic renal disease or history of renal transplant • Liver failure • Chronic renal disease or history of renal transplant • Osteoporosis • Low bone density LABORATORY STUDIES Vitamin D levels are measured by total serum 25-hydroxyvitamin D [also referred to as 25(OH)D]2. Testing 25- hydroxyvitamin D is most useful in nutrition assessment, primarily due to its longer half-life and minimal effect of parathyroid hormone on circulating levels. Since the development of 1,25-dihydroxyvitamin D testing, proper utilization based on clinical need has been problematic. The circulating half-life of 1,25-dihydroxyvitamin D is relatively short, which limits utility for overall vitamin D assessment. 1,25-dihydroxyvitamin D testing can be useful in the diagnosis of renal dysfunction in conjunction with parathyroid hormone, as well as in specific disorders of mineral metabolism. Laboratory Approval Process Test requests for 1,25-dihydroxyvitamin D will be flagged for review by the lab and sent to the ordering provider for review. • Laboratory team responsibility: o Request for 1,25-dihydroxyvitamin D will be intercepted by the team and the provider form letter will be sent to the ordering provider. o After the ordering provider responds with their decision, the lab team will either: o Send the specimen for processing OR o Cancel the request and redirect, to 25(OH)D testing • The lab team will document the case and decision in their database • Provider responsibility: o In the event the ordering provider does not respond within two days, the request will be sent to the on-call provider for the group. o The on-call provider can decide to approve the testing or redirect testing if clinically indicated

Page 5

CLINICAL PATHWAY Page 5 of 12 Evaluation of Laboratory Results • Vitamin D status as measured by 25(OH)D: (interpretation should take into account time of year, skin color, and presence of obesity or medical condition) • Severe Deficiency = Less than 12 ng/mL o At-risk for rickets, defective bone mineralization, and fractures • Deficiency =13 to 19 ng/mL • Insufficiency = 20 to 29 ng/mL o At-risk for secondary hyperparathyroidism and decreased bone mineral density • Sufficiency = 30 to 100 ng/mL • Toxicity = Greater than100 ng/mL o Hypercalcemia o Gastrointestinal distress, bone pain o Hypercalciuria o Kidney stones o Hyperphosphatemia THERAPEUTICS Recommendations for supplementation: These recommendations do not differentiate between the use of cholecalciferol (D3) or ergocalciferol (D2), as there is insufficient data to show any significant difference in absorption, particularly at therapeutic levels5. For patients who require large weekly doses (i.e., 50,000 International Units2) is preferred: however, it should be noted that patient insurance may require prescription and prior authorization (PAR). The American Academy of Pediatrics recommends daily dosing; however, the dosing schedule (daily versus weekly) should be individualized to minimize financial issues and treatment burden, particularly in patients with chronic illness6. Other considerations include the potential for vitamin D toxicity if a weekly high-dose regimen is inadvertently continued or possible loss of efficacy if the weekly dose is missed. The Children’s Hospital Colorado Vitamin D Committee recommends that all individuals, who are supplemented, take once-daily vitamin D3 or its weekly equivalent to maintain serum 25(OH)D levels of at least 30 ng/mL. Table 1. Dosing Recommendations for Treatment 25(OH)D Level Daily dosing for children 0 to less than 10 years of age Daily dosing for patients 10 to 18 years of age Severe Deficiency: Less than 12 ng/mL 2000 International Units or 50 mcg (normal weight) 4000 International Units or 100 mcg (normal weight) 4000 International Units or 100 mcg (obese, BMI > 95%) 8000 International Units or 200 mcg (obese, BMI > 95%) Deficiency: 13 to 19 ng/mL 1000 International Units or 25 mcg (normal weight) 2000 International Units or 50 mcg (normal weight) 2000 International Units or 50 mcg (obese, BMI > 95%) 4000 International Units or 100 mcg (obese, BMI > 95%) Insufficiency: 20 to 29 ng/mL 400 to 800 International Units or 10 to 20 mcg (normal weight) 800 International Units or 20 mcg (normal weight)

Tags

Doxxly editorial guide

Vitamin D Deficiency Clinical Pathway: summary, contents and background

This guide helps you understand the scope of Vitamin D Deficiency Clinical Pathway before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Vitamin D Deficiency Clinical Pathway is a 12-page documentcredited to Orson H. Zephyr. A clinical pathway primarily for pediatric patients at risk of vitamin D deficiency. Covers risk-based screening, 25-hydroxyvitamin D testing, interpretation of laboratory results, supplementation by age and weight status, follow-up, prevention, and endocrinology referral. Includes frequently asked questions, education resources, a sample laboratory test review letter, references, and clinical improvement team details. Originated November 3, 2014; last reviewed or revised August 25, 2020. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Clinical pathway, Vitamin D deficiency, Pediatrics, Nutrition, Bone health, Laboratory testing, Vitamin D supplementation, Preventive care with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Clinical pathway, Vitamin D deficiency, Pediatrics, Nutrition, Bone health, Laboratory testing, Vitamin D supplementation, Preventive care. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 12 pages in the player.

  1. Part 1

    Clinical pathway

    Use this section of the reading guide to identify how Clinical pathway appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Vitamin D deficiency

    Use this section of the reading guide to identify how Vitamin D deficiency appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Pediatrics

    Use this section of the reading guide to identify how Pediatrics appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Nutrition

    Use this section of the reading guide to identify how Nutrition appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    Bone health

    Use this section of the reading guide to identify how Bone health appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    Laboratory testing

    Use this section of the reading guide to identify how Laboratory testing appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    Vitamin D supplementation

    Use this section of the reading guide to identify how Vitamin D supplementation appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Preventive care

    Use this section of the reading guide to identify how Preventive care appears in Vitamin D Deficiency Clinical Pathway, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Orson H. Zephyr

Doxxly credits Orson H. Zephyr as the author or creator of Vitamin D Deficiency Clinical Pathway. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is childrenscolorado.org. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit childrenscolorado.org

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Vitamin D Deficiency Clinical Pathway, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Medicine & Wellbeing resources

Frequently asked questions about Vitamin D Deficiency Clinical Pathway

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Medicine & Wellbeing